OpenAlex
PricingAboutJobs
Log inGet started
Work

Impact of GLP-1 and GLP-1 Receptor Agonists on Cardiovascular Risk Factors in Type 2 Diabetes

HTML

Year: 2010
Type: article
Source: Current Diabetes Reviews
DOI: 10.2174/157339910791658853
Authors: Danilo Verge, Ximena Lopez
Institutions: Novo Nordisk Pharma, SA (Spain), Novo Nordisk (Denmark)
Language: English

Topic: Diabetes Treatment and Management
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Keywords: GLP-1 receptor agonists, glucagon-like peptide-1, type 2 diabetes, cardiovascular risk factors, liraglutide, exenatide, incretin-based therapy, weight loss, blood pressure, lipid profile, endothelial function, myocardial function, cardiovascular disease
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2007217090
FWCI: 3.301
Cites:
Cited by: 30
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security